Access Bio – A TRUSTED PARTNER IN GLOBAL HEALTH (original) (raw)

Access Bio Access Bio

ABOUT US

GLOBAL HEALTH

Access Bio’s mission is to improve the lives and well-being of people around the world. Through the development of in vitro diagnostics technology, Access Bio has successfully commercialized the highest quality products to battle malaria and other serious diseases.

We are a trusted partner to international public health agencies and organizations.

PRODUCTS

COVID-19

Diagnostic

Tests

Rapid

Diagnostic

Tests

Analyzers

Molecular

Tests

THE RANGE

LEADING THE FIGHT

AGAINST COVID-19

A challenge as complex as the Covid-19 pandemic requires
innovative, adaptable solutions. To meet the need for accurate,
reliable screening, we have a suite of products that includes
PCR, serology, and antigen testing.

NEWS

ANNOUNCEMENT OF THE RECORD DATE FOR DETERMINING SHAREHOLDERS

December 14, 2020September 23, 2021

ANNOUNCEMENT OF THE RECORD DATE FOR DETERMINING SHAREHOLDERS

In accordance with Article 16 (1) of the “Korean Depository Receipt Agreement” signed between Access Bio and Korea Securities Depository on March 11, 2013, the Record Date for determining shareholders in 2020 is December 31, 2020.

GETTING TESTS WHERE THEY’RE NEEDED MOST

July 12, 2020September 23, 2021

GETTING TESTS WHERE THEY’RE NEEDED MOST

Access Bio was founded on the basic principle of cherishing life and health for all people. The company has emerged as a leader in the diagnosis of infectious diseases. Although it provides a comprehensive portfolio, Access Bio is known for its work against malaria, HIV, HPV, and now, COVID-19.

THE GOAL: ENDING MALARIA IN OUR LIFETIME

June 20, 2020September 23, 2021

THE GOAL: ENDING MALARIA IN OUR LIFETIME

Malaria and its effects are primarily concentrated in poor, developing nations. in 2018, there were an estimated 228 million cases around the world and more than 400,000 deaths. Of those, more than 90% of cases and mortalities occurred in the sub-Saharan region of Africa, and children under the age of 5 account for two-thirds of all malaria deaths worldwide.

GLOBAL

OPERATIONS

AND REACH

ACCESSBIO

INVESTORS

WE ARE

HIRING

GET IN TOUCH

CONNECT WITH

US HERE AND

WE’LL BE TOUCH

We are always seeking to collaborate with forward-thinking individuals, organizations, and institutions.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.